From the data in this review, it emerges that members of the SOCS protein family, as physiological intracellular negative regulators of cytokine signaling, could be considered as valid candidates in the treatment of inflammatory skin diseases to suppress the harmful, unsteady, and prolonged signaling of inflammatory cytokines through the modulation of the JAK/STAT signal pathway. The gene discussed is CISH; the disease is inflammatory skin disease.